Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting

被引：0
|
作者：
Michael Scott Kook
Susan Simonyi
Yong Ho Sohn
Chan Yun Kim
Ki Ho Park
机构：
[1] Asan Medical Centre,Department of Ophthalmology
[2] Allergan Singapore Pte,Department of Ophthalmology
[3] Ltd.,Department of Ophthalmology
[4] Mapletree Business City,undefined
[5] Kim’s Eye Hospital,undefined
[6] Yonsei University,undefined
[7] College of Medicine,undefined
[8] Seoul National University Hospital,undefined
来源：
Japanese Journal of Ophthalmology | 2015年 / 59卷
关键词：
Bimatoprost; Glaucoma; Hyperemia; Ocular hypertension; Prostamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：325 / 334
页数：9
相关论文
共 50 条
  • [41] Laser trabeculoplasty for open-angle glaucoma and ocular hypertension
    Rolim-de-Moura, Christiane R.
    Paranhos Jr, Augusto
    Loutfi, Mohamed
    Burton, David
    Wormald, Richard
    Evans, Jennifer R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (08):
  • [42] Brinzolamide/Timolol In Open-Angle Glaucoma and Ocular Hypertension
    Croxtall, Jamie D.
    Scott, Lesley J.
    DRUGS & AGING, 2009, 26 (05) : 437 - 446
  • [43] A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
    Stevens, Annemie
    Iliev, Milko E.
    de Jong, Leo
    Grobeiu, Ioana
    Hommer, Anton
    CLINICAL OPHTHALMOLOGY, 2016, 10 : 635 - 641
  • [44] Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension
    Mark B. Abelson
    Michael Mroz
    Sarah A. Rosner
    Monte S. Dirks
    Dean Hirabayashi
    Advances in Therapy, 2003, 20 : 1 - 13
  • [45] Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension
    Abelson, MB
    Mroz, M
    Rosner, SA
    Dirks, MS
    Hirabayashi, D
    ADVANCES IN THERAPY, 2003, 20 (01) : 1 - 13
  • [46] MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension
    Stalmans, Ingeborg
    Lim, Kin Sheng
    Oddone, Francesco
    Fichtl, Marek
    Belda, Jose I.
    Hommer, Anton
    Laganovska, Guna
    Schweitzer, Cedric
    Voykov, Bogomil
    Zarnowski, Tomasz
    Hollo, Gabor
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (01) : 179 - 190
  • [47] MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension
    Ingeborg Stalmans
    Kin Sheng Lim
    Francesco Oddone
    Marek Fichtl
    Jose I. Belda
    Anton Hommer
    Guna Laganovska
    Cédric Schweitzer
    Bogomil Voykov
    Tomasz Zarnowski
    Gábor Holló
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 179 - 190
  • [48] Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
    DuBiner, Harvey B.
    Hubatsch, Douglas A.
    BMC OPHTHALMOLOGY, 2014, 14
  • [49] Intraocular pressure and ocular hemodynamics in patients with primary open-angle glaucoma treated with the combination of morning dosing of bimatoprost and dorzolamide hydrochloride
    Stankiewicz, Andrzej
    Misiuk-Hojlo, Marta
    Grabska-Liberek, Iwona
    Romanowska-Dixon, Bozena
    Wierzbowska, Joanna
    Wasyluk, Jaromir
    Mulak, Malgorzata
    Szuscik, Iwona
    Sierdzinski, Janusz
    Ehrlich, Rita
    Siesky, Brent
    Harris, Alon
    ACTA OPHTHALMOLOGICA, 2011, 89 (01) : E57 - E63
  • [50] Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension
    Xu, Kai Man
    Cho, Ryan
    Chan, Toby Yiu Bong
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 2385 - 2390
12345